Literature DB >> 30101215

MicroRNA-146a & hematopoiesis: friend or foe in atherosclerosis.

Robert L Raffai1.   

Abstract

Entities:  

Year:  2018        PMID： 30101215      PMCID： PMC6086356          DOI： 10.21037/ncri.2018.06.08

Source DB:  PubMed          Journal:  Noncoding RNA Investig        ISSN： 2522-6673


× No keyword cloud information.
  20 in total

1.  Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata.

Authors:  Filip K Swirski; Peter Libby; Elena Aikawa; Pilar Alcaide; F William Luscinskas; Ralph Weissleder; Mikael J Pittet
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

Review 2.  Targeted Delivery of Shear Stress-Inducible Micrornas by Nanoparticles to Prevent Vulnerable Atherosclerotic Lesions.

Authors:  Wing Tak Wong; Shuangtao Ma; Xiao Yu Tian; Andrea Banuet Gonzalez; Eno E Ebong; Haifa Shen
Journal:  Methodist Debakey Cardiovasc J       Date:  2016-09

3.  Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis.

Authors:  Katey J Rayner; Frederick J Sheedy; Christine C Esau; Farah N Hussain; Ryan E Temel; Saj Parathath; Janine M van Gils; Alistair J Rayner; Aaron N Chang; Yajaira Suarez; Carlos Fernandez-Hernando; Edward A Fisher; Kathryn J Moore
Journal:  J Clin Invest       Date:  2011-06-06       Impact factor: 14.808

Review 4.  MicroRNA Regulation of Atherosclerosis.

Authors:  Mark W Feinberg; Kathryn J Moore
Journal:  Circ Res       Date:  2016-02-19       Impact factor: 17.367

5.  MiR-33 contributes to the regulation of cholesterol homeostasis.

Authors:  Katey J Rayner; Yajaira Suárez; Alberto Dávalos; Saj Parathath; Michael L Fitzgerald; Norimasa Tamehiro; Edward A Fisher; Kathryn J Moore; Carlos Fernández-Hernando
Journal:  Science       Date:  2010-05-13       Impact factor: 47.728

Review 6.  The plaque "micro" environment: microRNAs control the risk and the development of atherosclerosis.

Authors:  Katey J Rayner; Kathryn J Moore
Journal:  Curr Atheroscler Rep       Date:  2012-10       Impact factor: 5.113

7.  MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages.

Authors:  Maliheh Nazari-Jahantigh; Yuanyuan Wei; Heidi Noels; Shamima Akhtar; Zhe Zhou; Rory R Koenen; Kathrin Heyll; Felix Gremse; Fabian Kiessling; Jochen Grommes; Christian Weber; Andreas Schober
Journal:  J Clin Invest       Date:  2012-10-08       Impact factor: 14.808

8.  Systemic delivery of microRNA-181b inhibits nuclear factor-κB activation, vascular inflammation, and atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Xinghui Sun; Shaolin He; A K M Wara; Basak Icli; Eugenia Shvartz; Yevgenia Tesmenitsky; Nathan Belkin; Dazhu Li; Timothy S Blackwell; Galina K Sukhova; Kevin Croce; Mark W Feinberg
Journal:  Circ Res       Date:  2013-10-01       Impact factor: 17.367

9.  MicroRNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways.

Authors:  Henry S Cheng; Nirojini Sivachandran; Andrew Lau; Emilie Boudreau; Jimmy L Zhao; David Baltimore; Paul Delgado-Olguin; Myron I Cybulsky; Jason E Fish
Journal:  EMBO Mol Med       Date:  2013-06-03       Impact factor: 12.137

10.  E-selectin-targeting delivery of microRNAs by microparticles ameliorates endothelial inflammation and atherosclerosis.

Authors:  Shuangtao Ma; Xiao Yu Tian; Yunrong Zhang; Chaofeng Mu; Haifa Shen; Jean Bismuth; Henry J Pownall; Yu Huang; Wing Tak Wong
Journal:  Sci Rep       Date:  2016-03-09       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.